웨스턴 블롯팅 시장 : 제품, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Western Blotting Market was valued at USD 622.05 million in 2023, expected to reach USD 734.75 million in 2024, and is projected to grow at a CAGR of 18.60%, to USD 2,053.55 million by 2030.

Western blotting, also known as protein immunoblotting, is a widely used analytical technique in molecular biology and biochemistry for detecting specific proteins in a tissue homogenate or extract. The method's scope extends from academic research labs to clinical settings, driven by its foundational role in studying protein structure, function, and modifications, essential for understanding diseases, especially cancer, neurodegenerative disorders, and infectious diseases. The necessity of western blotting lies in its high specificity and sensitivity, allowing for the precise identification and quantification of protein expression levels in complex samples, which is crucial for accurate biological assessments and therapeutic research. Its application is diverse, encompassing areas like drug discovery, diagnostics, and personalized medicine, with academic and research institutions, hospitals, and biotechnology companies being key end-users.

The market growth is primarily influenced by increased funding in proteomics research, advancements in antibodies and reagents used, and the rising prevalence of chronic diseases which require targeted treatments. Latest market opportunities include the integration of automated and high-throughput western blotting systems, which enhance throughput and reproducibility, addressing the demand from high-volume labs and new entrants in the biotechnology sector. While promising, the market faces challenges such as the labor-intensive nature of traditional western blotting, high costs of automated systems, and the availability of alternative protein analysis techniques like ELISA and mass spectrometry which offer less time-consuming workflows.

Areas ripe for innovation include the development of miniaturized and multiplexed western blotting platforms, leveraging novel detection technologies that improve speed and data accuracy. Business growth can also be supported by enhanced software solutions for data analysis and management, offering user-friendly interfaces and improved functionality. The market is evolving towards integration with holistic omics strategies, mandating vendors to provide comprehensive solutions encompassing sample preparation to analysis, thereby focusing not only on product development but also on collaboration with researchers to tailor solutions that meet emerging scientific needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Western Blotting Market

The Western Blotting Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising burden of chronic diseases across the globe
  • Increasing research activities in the biotech and pharma sector government funding in the field of biomedical research
  • Growing demand for personalized medicine and the rising prevalence of HIV
• Market Restraints
  • Limited availability of skilled and professional lab technicians
• Market Opportunities
  • Expanding production of genetically modified crops
  • Increasing R&D investment by the pharma and biotech companies
  • Rising investments in proteomics research activities
• Market Challenges
  • Availability of alternative technologies

Porter's Five Forces: A Strategic Tool for Navigating the Western Blotting Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Western Blotting Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Western Blotting Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Western Blotting Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Western Blotting Market

A detailed market share analysis in the Western Blotting Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Western Blotting Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Western Blotting Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Western Blotting Market

A strategic analysis of the Western Blotting Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Western Blotting Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Aviva Systems Biology Corporation, Azure Biosystems, Inc, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biointron Biological Inc., CANDOR Bioscience GmbH, Danaher Corporation, EMD Millipore Corporation, GE Healthcare, Geno Technology Inc, Merck KGaA, PerkinElmer, Inc., Promega Corporation, Rockland Immunochemicals Inc., Takara Bio Inc, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Western Blotting Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Antibodies & Conjugates, Kits, Membranes & Filter Papers, and Reagents & Buffers. The Instruments is further studied across Blotting Systems, Electrophoresis Instruments, and Imagers. The Blotting Systems is further studied across Semi-Dry Blotting Systems and Wet Blotting Systems. The Imagers is further studied across Chemiluminescent Imagers and Fluorescent Imagers.
• Based on Application, market is studied across Agriculture, Biomedical & Biochemical Research, Clinical Diagnostics, and Disease Diagnostics. The Clinical Diagnostics is further studied across Hepatitis, HIV, and Lyme Disease.
• Based on End-User, market is studied across Academic & Research Institutes, Biopharmaceutical & Biotechnology Companies, and Hospitals & Diagnostic Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising burden of chronic diseases across the globe
    • 5.1.1.2. Increasing research activities in the biotech and pharma sector government funding in the field of biomedical research
    • 5.1.1.3. Growing demand for personalized medicine and the rising prevalence of HIV
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of skilled and professional lab technicians
  • 5.1.3. Opportunities
    • 5.1.3.1. Expanding production of genetically modified crops
    • 5.1.3.2. Increasing R&D investment by the pharma and biotech companies
    • 5.1.3.3. Rising investments in proteomics research activities
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative technologies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Western Blotting Market, by Product

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Antibodies & Conjugates
  • 6.2.2. Kits
  • 6.2.3. Membranes & Filter Papers
  • 6.2.4. Reagents & Buffers
• 6.3. Instruments
  • 6.3.1. Blotting Systems
    • 6.3.1.1. Semi-Dry Blotting Systems
    • 6.3.1.2. Wet Blotting Systems
  • 6.3.2. Electrophoresis Instruments
  • 6.3.3. Imagers
    • 6.3.3.1. Chemiluminescent Imagers
    • 6.3.3.2. Fluorescent Imagers

7. Western Blotting Market, by Application

• 7.1. Introduction
• 7.2. Agriculture
• 7.3. Biomedical & Biochemical Research
• 7.4. Clinical Diagnostics
  • 7.4.1. Hepatitis
  • 7.4.2. HIV
  • 7.4.3. Lyme Disease
• 7.5. Disease Diagnostics

8. Western Blotting Market, by End-User

• 8.1. Introduction
• 8.2. Academic & Research Institutes
• 8.3. Biopharmaceutical & Biotechnology Companies
• 8.4. Hospitals & Diagnostic Laboratories

9. Americas Western Blotting Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Western Blotting Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Western Blotting Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam PLC
• 2. Aviva Systems Biology Corporation
• 3. Azure Biosystems, Inc
• 4. Bio-Rad Laboratories, Inc.
• 5. Bio-Techne Corporation
• 6. Biointron Biological Inc.
• 7. CANDOR Bioscience GmbH
• 8. Danaher Corporation
• 9. EMD Millipore Corporation
• 10. GE Healthcare
• 11. Geno Technology Inc
• 12. Merck KGaA
• 13. PerkinElmer, Inc.
• 14. Promega Corporation
• 15. Rockland Immunochemicals Inc.
• 16. Takara Bio Inc
• 17. Thermo Fisher Scientific, Inc.